MX364611B - Poliamidas con funcionalidad amina. - Google Patents

Poliamidas con funcionalidad amina.

Info

Publication number
MX364611B
MX364611B MX2015012119A MX2015012119A MX364611B MX 364611 B MX364611 B MX 364611B MX 2015012119 A MX2015012119 A MX 2015012119A MX 2015012119 A MX2015012119 A MX 2015012119A MX 364611 B MX364611 B MX 364611B
Authority
MX
Mexico
Prior art keywords
amine functional
functional polyamides
infection
amine
polyamides
Prior art date
Application number
MX2015012119A
Other languages
English (en)
Other versions
MX2015012119A (es
Inventor
J Miller Robert
Dhal Pradeep
Yang Kanwen
Randall Holms-Farley Stephen
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2015012119A publication Critical patent/MX2015012119A/es
Publication of MX364611B publication Critical patent/MX364611B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/668—Polyesters containing oxygen in the form of ether groups derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/672—Dicarboxylic acids and dihydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0273—Polyamines containing heterocyclic moieties in the main chain
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0622—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • C08G73/0627—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule

Abstract

Las poliamidas con funcionalidad amina comprenden grupos amina y amonio a lo largo de la cadena polimérica. Las poliamidas con funcionalidad amina pueden usarse como agentes farmacéuticos y en composiciones farmacéuticas. Las poliamidas con funcionalidad amina son particularmente útiles en el tratamiento o prevención de mucositis e infección, específicamente mucositis oral, infección del sitio quirúrgico e infección pulmonar asociada con fibrosis quística.
MX2015012119A 2013-03-15 2014-03-11 Poliamidas con funcionalidad amina. MX364611B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361790231P 2013-03-15 2013-03-15
PCT/US2014/022984 WO2014150338A1 (en) 2013-03-15 2014-03-11 Amine functional polyamides

Publications (2)

Publication Number Publication Date
MX2015012119A MX2015012119A (es) 2016-05-18
MX364611B true MX364611B (es) 2019-05-02

Family

ID=50390295

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015013262A MX2015013262A (es) 2013-03-15 2014-03-11 Composiciones antimicrobianas de poliamida y tratamiento de mastitis.
MX2015012119A MX364611B (es) 2013-03-15 2014-03-11 Poliamidas con funcionalidad amina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015013262A MX2015013262A (es) 2013-03-15 2014-03-11 Composiciones antimicrobianas de poliamida y tratamiento de mastitis.

Country Status (22)

Country Link
US (3) US10131744B2 (es)
EP (2) EP2970586B1 (es)
JP (4) JP6359630B2 (es)
KR (2) KR102233537B1 (es)
CN (2) CN105189607B (es)
AR (1) AR095366A1 (es)
AU (2) AU2014237169B2 (es)
BR (1) BR112015022224A2 (es)
CA (2) CA2906334C (es)
CL (1) CL2015002762A1 (es)
EA (1) EA030750B1 (es)
ES (1) ES2835382T3 (es)
HK (2) HK1215537A1 (es)
IL (1) IL241405A0 (es)
MX (2) MX2015013262A (es)
NZ (1) NZ712876A (es)
RU (1) RU2644554C2 (es)
SG (1) SG11201506359UA (es)
TW (2) TWI624263B (es)
UA (1) UA119642C2 (es)
WO (2) WO2014150338A1 (es)
ZA (1) ZA201506808B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA119642C2 (uk) 2013-03-15 2019-07-25 Меріал, Інк. Протимікробні поліамідні композиції та лікування маститу
WO2016007821A2 (en) * 2014-07-11 2016-01-14 Genzyme Corporation Main chain polyamines
CN104292148A (zh) * 2014-09-22 2015-01-21 西南科技大学 一种橡胶或树脂光稳定剂的制备方法
CN107735426A (zh) * 2015-07-09 2018-02-23 汉高知识产权控股有限责任公司 低粘度透明聚酰胺
AU2016350868B2 (en) * 2015-11-03 2022-03-31 Zoetis Services Llc Sol-gel polymer composites and uses thereof
EA039370B1 (ru) * 2016-04-14 2022-01-19 Мериал, Инк. Иммуногенная многодозовая композиция, содержащая антимикробный полиамидный консервант
KR20190018317A (ko) * 2017-08-14 2019-02-22 한국생명공학연구원 모노아세틸디아실글리세롤 화합물을 함유하는 슈도모나스 속 미생물 감염증의 예방 또는 치료용 조성물
US10836864B2 (en) 2017-12-12 2020-11-17 International Business Machines Corporation Chemical compositions with antimicrobial functionality
US10595527B2 (en) 2017-12-12 2020-03-24 International Business Machines Corporation Antimicrobial polymers capable of supramolecular assembly
US10687528B2 (en) 2017-12-12 2020-06-23 International Business Machines Corporation Antimicrobial polymers with enhanced functionalities
US10667514B2 (en) 2017-12-12 2020-06-02 International Business Machines Corporation Antimicrobial ionene compositions with a variety of functional groups
US10743537B2 (en) 2017-12-12 2020-08-18 International Business Machines Corporation Monomer compositions with antimicrobial functionality
US10653142B2 (en) 2017-12-12 2020-05-19 International Business Machines Corporation Polymers with antimicrobial functionalities
US10687530B2 (en) 2017-12-12 2020-06-23 International Business Machines Corporation Hydrophilic polymers with antimicrobial functionalities
RU2732206C2 (ru) * 2018-12-29 2020-09-14 Вероника Андреевна Гусева Способ лечения маститов у крупного рогатого скота
KR102052086B1 (ko) * 2019-07-25 2019-12-04 복세원 젖소 유두 보호제 및 그 제조방법
CN111471630B (zh) * 2020-06-11 2021-11-02 鲁东大学 一株棒杆菌Ytld-phe09及其应用
CN114796583B (zh) * 2022-03-25 2023-02-10 浙江大学 一种基于聚硫辛酸的生物医用贴片材料及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3583946A (en) * 1969-04-24 1971-06-08 Monsanto Co Polyureas derived from dipiperidines
IT981412B (it) * 1973-03-15 1974-10-10 Montedison Spa Poliammidi da acidi eterociclici aromatici ortocarbossilici e pro cedimento per prepararle
US4070400A (en) * 1975-10-16 1978-01-24 Merck & Co., Inc. Diphenyl polyamides having a cyclohexylene moiety
DE2942680C2 (de) * 1979-10-23 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen Schmelzkleber auf Basis von Polyesteramiden und deren Verwendung zum Verkleben von organischen und anorganischen Substraten
JPS591531A (ja) * 1982-06-25 1984-01-06 Daicel Chem Ind Ltd 感温性高分子材料
JPS596220A (ja) * 1982-07-01 1984-01-13 Daicel Chem Ind Ltd 新規ポリアミド共重合体
US4462942A (en) * 1982-07-30 1984-07-31 Eli Lilly And Company A47934 Antibiotic and process for production thereof
JPH0228208A (ja) * 1988-04-28 1990-01-30 Japan Synthetic Rubber Co Ltd 感放射線性共重合体およびその製造方法
JPH03258832A (ja) * 1990-03-08 1991-11-19 Mitsubishi Kasei Corp 不飽和ポリアミド
US6369049B1 (en) * 1998-04-30 2002-04-09 Eli Lilly And Company Treatment of mastitis
US6203812B1 (en) * 1998-06-29 2001-03-20 Hydromer, Inc. Hydrophilic polymer blends used to prevent cow skin infections
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
PT1395289E (pt) 2000-06-08 2011-03-16 Sang Dr Christine Tratamento da dor neuropática com antagonistas do receptor de n-metil-d-aspartato (nmda)
WO2001096380A2 (en) * 2000-06-12 2001-12-20 University Of Saskatchewan IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN
GB0029004D0 (en) * 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
US20040013698A1 (en) * 2001-07-09 2004-01-22 Aust Duncan T Method for preparing topical preparations containing skin protective agents with enhanced barrier properties
DE102004054873A1 (de) * 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
US20110209228A1 (en) * 2008-03-13 2011-08-25 Benjamin Cocks Method of treatment using antimicrobial composition
EP2138171A1 (en) * 2008-06-18 2009-12-30 Istituto Superiore Di Sanita' Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis
WO2010054269A1 (en) 2008-11-07 2010-05-14 Novabay Pharmaceuticals, Inc. Antimicrobial n-chlorinated compositions
JP5808082B2 (ja) * 2010-04-30 2015-11-10 株式会社Adeka 細胞への水溶性高分子量物質の導入方法及び導入剤
US8758778B2 (en) 2010-09-16 2014-06-24 The Regents Of The University Of California Polymeric nano-carriers with a linear dual response mechanism and uses thereof
CN102653779B (zh) * 2011-03-04 2014-02-19 北京科润三联生物技术有限责任公司 一种新型重组抗菌多肽药物的制备方法
WO2012151554A1 (en) 2011-05-04 2012-11-08 President And Fellows Of Harvard College Polyamines for treating biofilms
DK2709619T3 (en) * 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
AU2013283375B2 (en) 2012-06-29 2018-04-26 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
UA119642C2 (uk) 2013-03-15 2019-07-25 Меріал, Інк. Протимікробні поліамідні композиції та лікування маститу

Also Published As

Publication number Publication date
US9326994B2 (en) 2016-05-03
MX2015013262A (es) 2016-04-04
US20160208046A1 (en) 2016-07-21
EA201591812A1 (ru) 2016-02-29
BR112015022224A2 (pt) 2017-07-18
AU2014237232A1 (en) 2015-10-22
AU2014237169A1 (en) 2015-10-29
TW201513872A (zh) 2015-04-16
CA2906334A1 (en) 2014-09-25
BR112015023445A8 (pt) 2022-06-28
BR112015023445A2 (es) 2017-08-29
JP2020045493A (ja) 2020-03-26
US20140271526A1 (en) 2014-09-18
AR095366A1 (es) 2015-10-14
JP2018188662A (ja) 2018-11-29
JP6359630B2 (ja) 2018-07-18
EP2970586B1 (en) 2022-12-07
SG11201506359UA (en) 2015-09-29
AU2014237232B9 (en) 2018-02-01
CN105338976A (zh) 2016-02-17
RU2644554C2 (ru) 2018-02-13
NZ712876A (en) 2016-09-30
KR20150131354A (ko) 2015-11-24
CN105189607A (zh) 2015-12-23
AU2014237232B2 (en) 2018-01-18
EP2968231A1 (en) 2016-01-20
CA2907045A1 (en) 2014-09-25
RU2015144224A (ru) 2017-04-21
EP2968231B1 (en) 2020-07-01
WO2014150451A1 (en) 2014-09-25
HK1215537A1 (zh) 2016-09-02
EA030750B1 (ru) 2018-09-28
US20140275469A1 (en) 2014-09-18
ZA201506808B (en) 2017-11-29
MX2015012119A (es) 2016-05-18
TW201513873A (zh) 2015-04-16
US10113032B2 (en) 2018-10-30
CN105189607B (zh) 2018-06-15
CA2906334C (en) 2023-03-14
EP2970586A1 (en) 2016-01-20
WO2014150338A1 (en) 2014-09-25
UA119642C2 (uk) 2019-07-25
CL2015002762A1 (es) 2016-04-08
US10131744B2 (en) 2018-11-20
KR20150132325A (ko) 2015-11-25
KR102233537B1 (ko) 2021-03-29
CA2907045C (en) 2020-12-08
TWI667028B (zh) 2019-08-01
JP2016516700A (ja) 2016-06-09
CN105338976B (zh) 2018-12-04
HK1220711A1 (zh) 2017-05-12
AU2014237169B2 (en) 2017-02-16
JP2016514192A (ja) 2016-05-19
ES2835382T3 (es) 2021-06-22
IL241405A0 (en) 2015-11-30
JP7000021B2 (ja) 2022-01-19
TWI624263B (zh) 2018-05-21

Similar Documents

Publication Publication Date Title
MX364611B (es) Poliamidas con funcionalidad amina.
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
MX2014012247A (es) Bacterias probioticas.
PH12015500724B1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
CY1120098T1 (el) Συνθεσεις που περιεχουν βορτιοξετινη και δονεπεζιλη
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
MX2016014699A (es) (s)-pirlindol o sus sales farmaceuticamente aceptables para uso en medicina.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017000447A (es) Poliaminas de cadena principal.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
WO2014197536A3 (en) Novel beta lactams as modulators of glutamate uptake and methods for use thereof
MX2021001361A (es) Composicion liquida de fibrinogeno humano.
WO2017079403A3 (en) Polymeric nanoparticles
CY1118117T1 (el) Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου
MX365285B (es) Complejo lubricante para la boca.
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
UA101533U (uk) Полівалентний оральний гель для лікування і профілактики післяімплантаційних ускладнень

Legal Events

Date Code Title Description
FG Grant or registration